LIFECORE BIOMEDICAL, INC. \DE\ financial data

Symbol
LFCR on Nasdaq
Location
Chaska, MN
Fiscal year end
25 May
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 265 % +34.7%
Quick Ratio 111 % +6.3%
Debt-to-equity 12.4K % +310%
Return On Assets -13.4 % -610%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.5M shares +21.3%
Common Stock, Shares, Outstanding 37.5M shares +21.3%
Entity Public Float 202M USD +31%
Common Stock, Value, Issued 37K USD +19.4%
Weighted Average Number of Shares Outstanding, Basic 37.4M shares +21.2%
Weighted Average Number of Shares Outstanding, Diluted 37.4M shares +21.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.04M USD -6.73%
Operating Income (Loss) -8.73M USD +26.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -32.1M USD -655%
Income Tax Expense (Benefit) 401K USD +473%
Net Income (Loss) Attributable to Parent -32.5M USD -597%
Earnings Per Share, Basic -1 USD/shares -590%
Earnings Per Share, Diluted -1 USD/shares -787%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 30.3M USD
Inventory, Net 33.8M USD -18.8%
Assets, Current 83.9M USD +13.1%
Property, Plant and Equipment, Net 129M USD -13.6%
Operating Lease, Right-of-Use Asset 2.23M USD -11%
Intangible Assets, Net (Excluding Goodwill) 4.2M USD 0%
Goodwill 13.9M USD 0%
Other Assets, Noncurrent 4.62M USD +34.7%
Assets 235M USD -4.71%
Accounts Payable, Current 10.1M USD -43.8%
Employee-related Liabilities, Current 4.16M USD -25.3%
Accrued Liabilities, Current 19.8M USD
Contract with Customer, Liability, Current 7.21M USD
Liabilities, Current 30M USD -26.1%
Contract with Customer, Liability, Noncurrent 1.17M USD -75.6%
Deferred Income Tax Liabilities, Net 552K USD +32.7%
Operating Lease, Liability, Noncurrent 1.21M USD
Other Liabilities, Noncurrent 7.97M USD +55.7%
Liabilities 198M USD -4.29%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -218M USD -19.3%
Stockholders' Equity Attributable to Parent -10.5M USD -168%
Liabilities and Equity 235M USD -4.71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.76M USD
Net Cash Provided by (Used in) Financing Activities -1.39M USD -227%
Net Cash Provided by (Used in) Investing Activities -1.74M USD +49.2%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 37.5M shares +21.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.36M USD +53.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.9M USD +242%
Interest Paid, Excluding Capitalized Interest, Operating Activities 265K USD -57.8%
Deferred Tax Assets, Valuation Allowance 54.7M USD +18.5%
Deferred Tax Assets, Gross 73.5M USD +9.96%
Operating Lease, Liability 1.58M USD
Depreciation 1.98M USD -0.6%
Payments to Acquire Property, Plant, and Equipment 1.74M USD -49.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12M USD +82%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD
Property, Plant and Equipment, Gross 188M USD -6.41%
Operating Lease, Liability, Current 368K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 414K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 410K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 136K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 144K USD
Deferred Tax Assets, Operating Loss Carryforwards 40.7M USD -0.32%
Preferred Stock, Shares Issued 44.1K shares +7.48%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 1.32M USD +4.09%
Lessee, Operating Lease, Liability, to be Paid, Year Four 148K USD
Operating Lease, Payments 102K USD +0.99%
Additional Paid in Capital 208M USD +16.1%
Preferred Stock, Shares Outstanding 44.1K shares +7.48%
Depreciation, Depletion and Amortization 1.98M USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance 18.8M USD -9.13%
Share-based Payment Arrangement, Expense 8.88M USD +84.1%
Interest Expense 17.6M USD +13.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%